Tenofovir Disoproxil · larger labeled portfolio than Emtricitabine/Tenofovir
SPL labels Tenofovir Disoproxil + Emtricitabine/Tenofovir as minor; Tenofovir Disoproxil 13 / Emtricitabine/Tenofovir 9 in that band.
Mechanism on file: These medications contain the same active ingredient. Taking both at once can lead to having too much of the medicine in your body.
FDA SPL severity: Minor
Tenofovir Disoproxil
Full Tenofovir Disoproxil label recordNucleotide Reverse Transcriptase Inhibitor
Tenofovir Disoproxil + Emtricitabine/Tenofovir · SPL mechanism field
These medications contain the same active ingredient. Taking both at once can lead to having too much of the medicine in your body.
Minor band excerpt · Tenofovir Disoproxil with Emtricitabine/Tenofovir
Drug interaction trials have been conducted with emtricitabine and tenofovir disoproxil fumarate, the components of TRUVADA. This section describes clinically relevant drug interactions observed with emtricitabine and tenofovir disoproxil fumarate [see Clinical Pharmacology (12.3) ] . Didanosine: Tenofovir disoproxil fumarate increases didanosine concentrations.
Tenofovir Disoproxil · 14 SPL pairs (broader portfolio than Emtricitabine/Tenofovir)
- Acyclovir minor
- Cidofovir minor
- Darunavir minor
- Efavirenz/Emtricitabine/Tenofovir minor
Emtricitabine/Tenofovir · 9 minor + 9 total pairs
- Acyclovir minor
- Cidofovir minor
- Darunavir minor
- Ganciclovir minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.